These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17615372)

  • 1. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR; Moulton KS; Kazlauskas A
    Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
    Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
    Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.
    Harb D; Bujold K; Febbraio M; Sirois MG; Ong H; Marleau S
    Cardiovasc Res; 2009 Jul; 83(1):42-51. PubMed ID: 19264766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
    Tarín C; Gomez M; Calvo E; López JA; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):27-32. PubMed ID: 18988893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
    Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
    Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice.
    Jagavelu K; Tietge UJ; Gaestel M; Drexler H; Schieffer B; Bavendiek U
    Circ Res; 2007 Nov; 101(11):1104-12. PubMed ID: 17885219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear stress regulates angiotensin type 1 receptor expression in endothelial cells.
    Ramkhelawon B; Vilar J; Rivas D; Mees B; de Crom R; Tedgui A; Lehoux S
    Circ Res; 2009 Oct; 105(9):869-75. PubMed ID: 19762680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
    Sandberg WJ; Halvorsen B; Yndestad A; Smith C; Otterdal K; Brosstad FR; Frøland SS; Olofsson PS; Damås JK; Gullestad L; Hansson GK; Oie E; Aukrust P
    Circ Res; 2009 Jan; 104(1):60-8. PubMed ID: 19023130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice.
    Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1474-8. PubMed ID: 15178562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice.
    Choi JH; Nam KH; Kim J; Baek MW; Park JE; Park HY; Kwon HJ; Kwon OS; Kim DY; Oh GT
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2404-9. PubMed ID: 16141407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
    Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
    Aslanian AM; Charo IF
    Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL
    Cardiovasc Res; 2008 Jul; 79(2):287-93. PubMed ID: 18453637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.